Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

NCI Translational Science Meeting Sessions to Be Videocast

Posted Aug 07 2011 10:31pm

NCI Director to Hold Town Hall Meeting

NCI Director Dr. Harold Varmus will host a Town Hall Meeting with staff July 27 at the Lipsett Amphitheater on the NIH campus in Bethesda, MD.

The event is open to the public and can be viewed live starting at 11:00 a.m. ET. An archived videocast of the meeting will be available a few days later.

For a biography of Dr. Varmus as well as other information and video presentations, please visit the NCI Director’s Page .

NCI Translational Science Meeting Sessions to Be Videocast

NCI Translational Science Meeting tile

The NCI Translational Science Meeting 2011: From Molecular Information to Cancer Medicine will be held on July 28 and 29 in Washington, DC. This year's meeting will explore the convergence of molecular information ("omics" technology) and clinical care, with the goal of accelerating early translational cancer research to speed therapeutic benefits to patients.

The meeting is by invitation only, but morning sessions will be videocast live and archived at http://videocast.nih.gov/ . Sessions that will be videocast include:

Thursday, July 28, 2011, from 8:00 a.m. to 12:30 p.m. ET

  • Opening Plenary Session
  • Galvanizing Examples: Session I
  • Welcome by NCI Director

Friday, July 29, 2011, from 8:00 a.m. to 12:00 noon ET

  • Opening Plenary Session
  • Galvanizing Examples: Session II

For more details on these sessions, please visit the meeting Web site .

Thai Princess Signs Agreement with NCI

H.R.H. Princess Chulabhorn Mahidol and NCI Director Dr. Harold Varmus sign a Natural Products Collaboration Agreement H.R.H. Princess Chulabhorn Mahidol and NCI Director Dr. Harold Varmus (seated) sign a Natural Products Collaboration Agreement, while Khuning Laxanachantom Laohaphan, Dr. Somsak Ruchirawat, and NCI's Dr. David Newman (left to right) look on.

Her Royal Highness Princess Chulabhorn Mahidol of Thailand visited NIH on July 21 and signed a Natural Product Collaboration Agreement with the Developmental Therapeutics Program (DTP) in NCI's Division of Cancer Treatment and Diagnosis.

H.R.H. Princess Chulabhorn, who has a Ph.D. in organic chemistry and has taught courses in natural products chemistry, is the founder and president of the Chulabhorn Research Institute (CRI), whose mission focuses on global collaboration and the application of translational discoveries to improve the quality of life for the people of Thailand.

DTP studies natural products and synthetic compounds to find disease-fighting compounds and is interested in investigating plant, terrestrial, and marine species native to Thailand that may have properties useful for treating cancer.

The agreement formalizes ongoing collaborations and the sharing of knowledge, expertise, and technology between NCI and CRI.

NCI's Early Detection Research Network Wins NASA Award

The National Aeronautics and Space Administration (NASA) has awarded NCI's Early Detection Research Network (EDRN) Informatics Team the NASA Honors Award for Group Achievement for the innovative and pioneering use of NASA data system technologies to promote data and specimen sharing among cancer biomarker researchers. 

The award will be presented to EDRN teams from NASA's Jet Propulsion Laboratory, NCI, Dartmouth, and the EDRN Data Management and Coordinating Center at Fred Hutchinson Cancer Research Center.

Under the leadership of Dr. Sudhir Srivastava, chief of NCI's Cancer Biomarkers Research Group in the Division of Cancer Prevention, the EDRN Informatics Team pioneered and deployed a highly distributed national data system to implement cancer biomarker data analysis and research. This project is a flagship example of successful technology infusion and transfer between agencies.

The informatics platform has enabled EDRN science teams to share and integrate diverse datasets and software platforms for complex biomarker research, including discovery and validation of cancer biomarkers.

Author and Oncologist Siddhartha Mukherjee Speaks at NIH

Pulitzer Prize-winning author Dr. Siddhartha Mukherjee delivered a special lecture titled "Constructing a History of Cancer" at the NIH main campus on June 15. The lecture was based on his book, The Emperor of All Maladies: A Biography of Cancer, which won the 2011 Pulitzer Prize for general nonfiction.

Dr. Mukherjee is an assistant professor in the Division of Hematology/Oncology at the Columbia University Medical Center. His lab focuses on the biology of hematopoiesis and leukemia. He has published a number of articles in Nature, the New England Journal of Medicine, the New York Times, and The New Republic.

View an excerpt of the presentation below, or view the full, hour-long lecture online .

You must have flash installed and enabled to view the video.

Latest Issue of CCR Connections Released

CCR Connections

A new issue of the NCI's Center for Cancer Research (CCR) news magazine, CCR Connections, is available online. 

The latest issue demonstrates that research advances come from tackling difficult questions by means of long-term investment and persistence. CCR-led research advances are highlighted, including a mouse model developed by CCR researchers to study the origins of metastatic prostate cancer and an anticancer target called heat shock protein 90.

Other articles include a look at the role that chromatin plays in gene regulation. This issue also includes a profile of CCR's Dr. Christina Annunziata, who has studied the NFkappaB pathway in several different cancers since she was a graduate student; and summaries of several recent CCR scientific publications and staff awards.

CCR Connections is published semiannually. Please send requests for print or online subscriptions to tellccr@mail.nih.gov .

    

Post a comment
Write a comment:

Related Searches